Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTOPUS: Ranibizumab and Mitomycin C in Trabeculectomy
NCT00661583Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Apr 2008
- Primary completion
- Sep 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ranibizumab in Glaucoma, sponsored by University of Colorado Denver. Primary endpoint: Ocular Adverse Events at 6 months. Started Apr 2008; status: completed.
02
Drugs
ranibizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00661583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661583.